We are live on
!
Find out more
Ninety One (UK) Portfolio holdings
AUM
$44.7B
1-Year Est. Return
17.24%
This Fund
S&P 500
This Quarter
Est. Return
-4.46%
1 Year Est. Return
+17.24%
3 Year Est. Return
+87.79%
5 Year Est. Return
+111.34%
10 Year Est. Return
+534.1%
AUM
$43.1B
AUM Growth
-$3.52B
(-7.5%)
Cap. Flow
+$51.7M
Cap. Flow
% of AUM
0.12%
Top 10 Holdings %
Top 10 Hldgs %
35.5%
Holding
275
New
50
Increased
77
Reduced
93
Closed
38
Top Buys
| 1 |
Apple
AAPL
|
+$538M |
| 2 |
AstraZeneca
AZN
|
+$395M |
| 3 |
Edwards Lifesciences
EW
|
+$384M |
| 4 |
Chevron
CVX
|
+$291M |
| 5 |
Intuit
INTU
|
+$233M |
Top Sells
| 1 |
Icon
ICLR
|
+$537M |
| 2 |
Microsoft
MSFT
|
+$501M |
| 3 |
TKO Group
TKO
|
+$284M |
| 4 |
Broadcom
AVGO
|
+$237M |
| 5 |
NVIDIA
NVDA
|
+$226M |
Sector Composition
| 1 | Technology | 27.04% |
| 2 | Financials | 17.55% |
| 3 | Healthcare | 12.74% |
| 4 | Communication Services | 12.51% |
| 5 | Consumer Discretionary | 7.17% |
Similar funds
AS
LP
Ninety One (UK)'s Q1 2026 Portfolio in Review
As of Q1 2026, Ninety One (UK) held 275 positions worth $43.1B, down 7.5% from $46.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Ninety One (UK)'s Q1 2026 filing shows 50 new, 77 increased, 93 reduced and 38 closed positions. Its largest new stake was AstraZeneca: 2,047,019 shares worth $397M. The largest sale was Icon, an estimated $537M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.
- Ninety One (UK)'s largest Q1 2026 buy was AstraZeneca: 2,047,019 shares worth $397M.
- Ninety One (UK) added most to Apple in Q1 2026, an estimated $538M increase.
- Ninety One (UK)'s biggest Q1 2026 reduction was Microsoft, cutting an estimated $501M.
- Ninety One (UK) fully exited Icon in Q1 2026, selling an estimated $537M.
- Ninety One (UK)'s ten largest holdings make up 35% of its $43.1B portfolio in Q1 2026.
- Ninety One (UK) opened 50 new positions and closed 38 in Q1 2026.
- Ninety One (UK)'s portfolio value fell 7.5% quarter-over-quarter to $43.1B.
Based on Ninety One (UK)'s 13F filing for Q1 2026, filed 24 Apr 2026.